Emcure Pharmaceuticals Ltd

BSE: 544210

total announcements

544210.BO · 15 min delayed

BSECompany UpdateM&A1h ago

Update on completion of acquisition of shares of Gennova Biopharmaceuticals Limited

Emcure Pharmaceuticals Ltd has completed the acquisition of 12.05% of Gennova Biopharmaceuticals Ltd's shares, making Gennova a wholly-owned subsidiary. The acquisition was completed on July 21, 2026, for an aggregate consideration of Rs. 2,318.7 Million.

Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Completion of 2nd term of Independent Director

Emcure Pharmaceuticals Ltd has announced the completion of the 2nd term of Independent Director Mr. P.S. Jayakumar, who will cease to be a Director and Chairman/Member of various Board Committees with effect from July 21, 2026.